ADAR1 Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$75K	–	204
2025 Q1	$75K	Sell	10,000 -25,000	-71%	-$188K	0.01%	168
2024 Q4	$263K	Hold	35,000	–	–	0.05%	137
2024 Q3	$266K	Buy	35,000 +5,600	+19%	+$42.6K	0.04%	139
2024 Q2	$182K	Buy	+29,400	New	+$182K	0.03%	140